VRDN Competitors & Alternatives
Compare Viridian Therapeutics Inc with similar stocks in the same industry
Biotechnology
VRDN
Main Stock$16.35
Tradestie Score
62
Market Cap
$1.74B
Revenue Growth
1.0%
Analyst Upside
+107.6%
Top Competitors
219 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
OCUL
Ocular Therapeutix, Inc.
|
$8.94
|
$1.92B | - | 61 | Compare |
|
CELC
Celcuity Inc. Common Stock
|
$88.55
|
$1.92B | - | 53 | Compare |
|
LQDA
Liquidia Corporation Common Stock
|
$71.23
|
$1.90B | 421.3 | 67 | Compare |
|
VERA
Vera Therapeutics, Inc. Class A Common Stock
|
$34.26
|
$1.84B | - | 60 | Compare |
|
IMCR
Immunocore Holdings plc American Depositary Shares
|
$28.96
|
$1.81B | - | 59 | Compare |
|
ABCL
AbCellera Biologics Inc. Common Shares
|
$5.24
|
$1.78B | - | 57 | Compare |
|
DYN
Dyne Therapeutics, Inc. Common Stock
|
$18.19
|
$1.78B | - | 58 | Compare |
|
CLDX
Celldex Therapeutics, Inc
|
$31.27
|
$1.68B | - | 59 | Compare |
|
MNKD
Mannkind Corporation
|
$3.66
|
$1.65B | - | 64 | Compare |
|
EWTX
Edgewise Therapeutics, Inc. Common Stock
|
$34.83
|
$1.63B | - | 56 | Compare |
More VRDN Analysis
Data updated: Jun 13, 2026 | Industry: Biotechnology (SIC 2834)
219 stocks in this industry